PRESENTATION · Sep 2025 · PDF
Presentations & Publications
Achondroplasia
PRESENTATION · Dec 2024 · PDF
Infigratinib - ISDS 2024 - Clinical Development Program Update
PRESENTATION · Dec 2024 · PDF
BBIO - Infigratinib - PROPEL 2 Data Update and ACCEL Program Initiation
PRESENTATION · Dec 2023 · PDF
Infigratinib - ESPE 2023 - Updated Six Month Results in Phase 2 Cohort 5 Study
PRESENTATION · Dec 2023 · PDF
Infigratinib - ENDO 2023 - Updated Six Month Results in Phase 2 Cohort 5 Study
PRESENTATION · Dec 2023 · PDF
Infigratinib - ENDO 2023 - Murine Models in Achondroplasia and Hypochondroplasia
PRESENTATION · Dec 2023 · PDF
Infigratinib - ENDO 2023 - PROPEL, PROPEL 2 and PROPEL OLE
PRESENTATION · Dec 2023 · PDF
Infigratinib - ENDO 2023 -Evaluation of Bone Mineral Density
PRESENTATION · Dec 2023 · PDF